Quantcast

Latest Diabetes management Stories

2014-05-27 12:31:24

LONDON, May 27, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Blood Glucose Testing and Diabetes Management http://www.reportbuyer.com/pharma_healthcare/diseases/diabetes/blood_glucose_testing_diabetes_management.html There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease--sometimes referred to as juvenile...

2014-05-27 12:27:43

Traditional Type 2 Diabetes Drug Attributes Continue to be Key Even as First-Line Treatment Paradigms Shift, According to Findings from Decision Resources Group BURLINGTON, Mass., May 27, 2014 /PRNewswire/ -- Decision Resources Group finds that Eli Lilly's insulin peglispro is set to become the clinical gold-standard in the treatment of patients with type 2 diabetes inadequately controlled with diet and exercise, when metformin is not a therapeutic option. Although metformin continues to...

2014-05-27 08:26:13

3 -Year Follow-Up Data from STAMPEDE Trial Highlights Ethicon's Commitment to Addressing the Global Health Burdens of Obesity and Diabetes CINCINNATI, May 27, 2014 /PRNewswire/ -- A study funded primarily by Ethicon and published in the May 22 issue of The New England Journal of Medicine demonstrates that at 3-year follow-up, improved glycemic control and reduction in diabetes medications seen in patients with type 2 diabetes mellitus (T2DM) who underwent bariatric surgery is...

2014-05-26 13:31:52

University of Montreal A signal that promotes insulin secretion and reduces hyperglycemia in a type 2 diabetes animal model is enhanced by the inhibition of a novel enzyme discovered by CHUM Research Centre (CRCHUM) and University of Montreal researchers. The team is part of the Montreal Diabetes Research Center and their study, published recently in Cell Metabolism, was directed by researchers Marc Prentki and Murthy Madiraju. Insulin is an important hormone in our body that controls...

2014-05-26 08:22:34

INVOKANA((TM) )offers a new approach to treatment TORONTO, May 26, 2014 /CNW/ - Janssen Inc. announced today that Health Canada has approved INVOKANA((TM) )(canagliflozin), an oral, once-daily prescription treatment used to lower blood glucose (sugar) levels in adults with type 2 diabetes.(1) INVOKANA((TM) )belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors that offers a novel approach to treating diabetes by increasing the loss of...

diabetes and heart disease
2014-05-24 05:47:05

redOrbit Staff & Wire Reports - Your Universe Online Women with type 2 diabetes are far more likely to develop heart disease than their male counterparts, according to new research appearing in the latest edition of the European Association for the Study of Diabetes journal Diabetologia. In what Rebecca Smith of The Telegraph called “the largest study of its kind,” an international team of researchers conducted a systematic review and meta-analysis of roughly 850,000 patients...

2014-05-23 16:23:50

BERKELEY, Calif., May 23, 2014 /PRNewswire-iReach/ -- Diapression - Connect with help. (Logo: http://photos.prnewswire.com/prnh/20140522/90764) In recognition of Mental Health Awareness Month, Diabetes Advocates, a program of the Diabetes Hands Foundation, calls for greater patient attention to the relationship between diabetes and depression. Diabetes Advocates agrees with the opening sentence in a 2010 article in the Patient Education and Counseling: "There is an urgent need for more...

2014-05-23 08:23:45

European Commission approves third product from the Boehringer Ingelheim and Lilly Diabetes alliance RIDGEFIELD, Conn. and INDIANAPOLIS, May 23, 2014 /PRNewswire/ -- The European Commission granted marketing authorization for Jardiance(®) (empagliflozin) tablets, a sodium glucose co-transporter 2 (SGLT2) inhibitor, for the treatment of type 2 diabetes mellitus (T2D) to improve glycemic control in adults in Europe, Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company...

Newly Discovered Compound Slows Natural Degradation Of Insulin In The Body
2014-05-22 03:32:32

By Peter Reuell, Harvard University With the discovery of a compound that can slow the degradation of insulin in animals, scientists at Harvard have opened the door to a potential new treatment for diabetes. The new approach, described by David Liu, professor of chemistry and chemical biology, and Alan Saghatelian, associate professor of chemistry and chemical biology, uses the compound to inhibit insulin-degrading enzyme (IDE). Inhibiting IDE in mice, they have shown, elevates insulin...

2014-05-22 08:28:42

DUBLIN, May 22, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/wqkgq3/continuous) has announced the addition of the "Global Continuous Glucose Monitoring (Guardian Real Time, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo CGM Systems) Market - Forecast to 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The rapid rise in diabetic population across the globe has considerably...


Latest Diabetes management Reference Libraries

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

More Articles (1 articles) »
Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.